MROPF
Price
$0.13
Change
-$0.20 (-60.61%)
Updated
Sep 25 closing price
Capitalization
695.4M
PRE
Price
$5.66
Change
-$0.27 (-4.55%)
Updated
Jan 17 closing price
Capitalization
51.51M
Ad is loading...

MROPF vs PRE

Header iconMROPF vs PRE Comparison
Open Charts MROPF vs PREBanner chart's image
MICROPORT CARDIOFLOW MEDTECH
Price$0.13
Change-$0.20 (-60.61%)
Volume$100
Capitalization695.4M
Prenetics Global
Price$5.66
Change-$0.27 (-4.55%)
Volume$5.5K
Capitalization51.51M
MROPF vs PRE Comparison Chart
Loading...
PRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MROPF vs. PRE commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MROPF is a Hold and PRE is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (MROPF: $0.13 vs. PRE: $5.66)
Brand notoriety: MROPF and PRE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MROPF: 100% vs. PRE: 51%
Market capitalization -- MROPF: $695.4M vs. PRE: $51.51M
MROPF [@Medical Specialties] is valued at $695.4M. PRE’s [@Medical Specialties] market capitalization is $51.51M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MROPF’s FA Score shows that 1 FA rating(s) are green whilePRE’s FA Score has 1 green FA rating(s).

  • MROPF’s FA Score: 1 green, 4 red.
  • PRE’s FA Score: 1 green, 4 red.
According to our system of comparison, PRE is a better buy in the long-term than MROPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRE’s TA Score shows that 4 TA indicator(s) are bullish.

  • PRE’s TA Score: 4 bullish, 3 bearish.

Price Growth

MROPF (@Medical Specialties) experienced а 0.00% price change this week, while PRE (@Medical Specialties) price change was +4.15% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

PRE is expected to report earnings on Mar 12, 2024.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MROPF($695M) has a higher market cap than PRE($51.5M). MROPF YTD gains are higher at: 0.000 vs. PRE (-2.491). PRE has higher annual earnings (EBITDA): -12.29M vs. MROPF (-118.59M). MROPF has more cash in the bank: 2.21B vs. PRE (68.8M). PRE has less debt than MROPF: PRE (5.26M) vs MROPF (126M). PRE has higher revenues than MROPF: PRE (280M) vs MROPF (201M).
MROPFPREMROPF / PRE
Capitalization695M51.5M1,350%
EBITDA-118.59M-12.29M965%
Gain YTD0.000-2.491-
P/E RatioN/A0.97-
Revenue201M280M72%
Total Cash2.21B68.8M3,215%
Total Debt126M5.26M2,397%
TECHNICAL ANALYSIS
Technical Analysis
MROPFPRE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 12 days ago
53%
Momentum
ODDS (%)
N/A
Bearish Trend 12 days ago
61%
MACD
ODDS (%)
N/A
Bearish Trend 12 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
1%
Bearish Trend 12 days ago
78%
TrendMonth
ODDS (%)
N/A
Bullish Trend 12 days ago
52%
Advances
ODDS (%)
N/A
Bullish Trend 27 days ago
73%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 12 days ago
80%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
40%
View a ticker or compare two or three
Ad is loading...
PRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MVIS1.440.22
+18.03%
MicroVision
COIN295.4813.85
+4.92%
Coinbase Global
TACT4.510.03
+0.67%
TransAct Technologies
SAFE17.00-0.09
-0.53%
Safehold
OPCH29.16-0.16
-0.55%
Option Care Health

MROPF and

Correlation & Price change

A.I.dvisor tells us that MROPF and MEDP have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MROPF and MEDP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MROPF
1D Price
Change %
MROPF100%
N/A
MEDP - MROPF
26%
Poorly correlated
+0.16%
SAFLF - MROPF
21%
Poorly correlated
N/A
STSS - MROPF
9%
Poorly correlated
-1.60%
PRE - MROPF
8%
Poorly correlated
-4.63%
OLYMY - MROPF
4%
Poorly correlated
+0.14%
More